Retraction notice to “Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved” [Arch. Biochem. Biophys. 689 (2020) 108461]
Archives of Biochemistry and Biophysics · 2026-09 · 783 · 110887
DOI: 10.1016/j.abb.2026.110887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-09. Verfasst von Peng Bian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics and Medical Record Management, Shandong Provincial Hospital, Jinan, 250021, China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Statistics and Medical Record Management, Shandong Provincial Hospital, Jinan, 250021, China.
- Department of Thyroid and Breast Surgery, Zibo Central Hospital, Zibo, 255036, China.
Zitieren
APA
Bian, P., Hu, W., Liu, C., & Li, L. (2026). Retraction notice to “Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved” [Arch. Biochem. Biophys. 689 (2020) 108461]. Archives of Biochemistry and Biophysics, 783, 110887. https://doi.org/10.1016/j.abb.2026.110887
Vancouver
Bian P, Hu W, Liu C, Li L. Retraction notice to “Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved” [Arch. Biochem. Biophys. 689 (2020) 108461]. Archives of Biochemistry and Biophysics. 2026;783:110887. doi:10.1016/j.abb.2026.110887
BibTeX
@article{Bian2026,
author = {Bian, Peng and Hu, Wei and Liu, Chuan and Li, Liang},
title = {Retraction notice to “Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved” [Arch. Biochem. Biophys. 689 (2020) 108461]},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
volume = {783},
pages = {110887},
doi = {10.1016/j.abb.2026.110887}
}
EUVIMED